T-Cell & NK-Cell Engaging Bispecific Antibodies Market, Global Outlook and Forecast 2022-2028
A Bispecific Antibodies is designed to bind two different targets or epitopes and can thereby exert two different functions. They are currently used to treat infectious, inflammatory, and malignant diseases.
This report contains market size and forecasts of T-Cell & NK-Cell Engaging Bispecific Antibodies in global, including the following market information:
Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five T-Cell & NK-Cell Engaging Bispecific Antibodies companies in 2021 (%)
The global T-Cell & NK-Cell Engaging Bispecific Antibodies market was valued at 485.7 million in 2021 and is projected to reach US$ 4927.4 million by 2028, at a CAGR of 39.2% during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
T-Cell Engagers Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of T-Cell & NK-Cell Engaging Bispecific Antibodies include Amgen, Immunocore, Johnson & Johnson, Roche, Pfizer, AbbVie, MacroGenics and Regeneron, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the T-Cell & NK-Cell Engaging Bispecific Antibodies manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Segment Percentages, by Type, 2021 (%)
Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Segment Percentages, by Application, 2021 (%)
Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies T-Cell & NK-Cell Engaging Bispecific Antibodies revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies T-Cell & NK-Cell Engaging Bispecific Antibodies revenues share in global market, 2021 (%)
Key companies T-Cell & NK-Cell Engaging Bispecific Antibodies sales in global market, 2017-2022 (Estimated), (K Units)
Key companies T-Cell & NK-Cell Engaging Bispecific Antibodies sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of T-Cell & NK-Cell Engaging Bispecific Antibodies in global, including the following market information:
Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five T-Cell & NK-Cell Engaging Bispecific Antibodies companies in 2021 (%)
The global T-Cell & NK-Cell Engaging Bispecific Antibodies market was valued at 485.7 million in 2021 and is projected to reach US$ 4927.4 million by 2028, at a CAGR of 39.2% during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
T-Cell Engagers Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of T-Cell & NK-Cell Engaging Bispecific Antibodies include Amgen, Immunocore, Johnson & Johnson, Roche, Pfizer, AbbVie, MacroGenics and Regeneron, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the T-Cell & NK-Cell Engaging Bispecific Antibodies manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Segment Percentages, by Type, 2021 (%)
- T-Cell Engagers
- NK-Cell Engagers
Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Segment Percentages, by Application, 2021 (%)
- Hematological Cancers
- Solid Tumors
Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies T-Cell & NK-Cell Engaging Bispecific Antibodies revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies T-Cell & NK-Cell Engaging Bispecific Antibodies revenues share in global market, 2021 (%)
Key companies T-Cell & NK-Cell Engaging Bispecific Antibodies sales in global market, 2017-2022 (Estimated), (K Units)
Key companies T-Cell & NK-Cell Engaging Bispecific Antibodies sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Amgen
- Immunocore
- Johnson & Johnson
- Roche
- Pfizer
- AbbVie
- MacroGenics
- Regeneron
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL T-CELL & NK-CELL ENGAGING BISPECIFIC ANTIBODIES OVERALL MARKET SIZE
2.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size: 2021 VS 2028
2.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, Prospects & Forecasts: 2017-2028
2.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top T-Cell & NK-Cell Engaging Bispecific Antibodies Players in Global Market
3.2 Top Global T-Cell & NK-Cell Engaging Bispecific Antibodies Companies Ranked by Revenue
3.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Companies
3.4 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Companies
3.5 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 T-Cell & NK-Cell Engaging Bispecific Antibodies Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers T-Cell & NK-Cell Engaging Bispecific Antibodies Product Type
3.8 Tier 1, Tier 2 and Tier 3 T-Cell & NK-Cell Engaging Bispecific Antibodies Players in Global Market
3.8.1 List of Global Tier 1 T-Cell & NK-Cell Engaging Bispecific Antibodies Companies
3.8.2 List of Global Tier 2 and Tier 3 T-Cell & NK-Cell Engaging Bispecific Antibodies Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size Markets, 2021 & 2028
4.1.2 T-Cell Engagers
4.1.3 NK-Cell Engagers
4.2 By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue & Forecasts
4.2.1 By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2017-2022
4.2.2 By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2023-2028
4.2.3 By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2017-2028
4.3 By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales & Forecasts
4.3.1 By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, 2017-2022
4.3.2 By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, 2023-2028
4.3.3 By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2017-2028
4.4 By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2021 & 2028
5.1.2 Hematological Cancers
5.1.3 Solid Tumors
5.2 By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue & Forecasts
5.2.1 By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2017-2022
5.2.2 By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2023-2028
5.2.3 By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2017-2028
5.3 By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales & Forecasts
5.3.1 By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, 2017-2022
5.3.2 By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, 2023-2028
5.3.3 By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2017-2028
5.4 By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2021 & 2028
6.2 By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue & Forecasts
6.2.1 By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2017-2022
6.2.2 By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2023-2028
6.2.3 By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2017-2028
6.3 By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales & Forecasts
6.3.1 By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, 2017-2022
6.3.2 By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, 2023-2028
6.3.3 By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2017-2028
6.4.2 By Country - North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, 2017-2028
6.4.3 US T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2017-2028
6.4.4 Canada T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2017-2028
6.4.5 Mexico T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2017-2028
6.5.2 By Country - Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, 2017-2028
6.5.3 Germany T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2017-2028
6.5.4 France T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2017-2028
6.5.5 U.K. T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2017-2028
6.5.6 Italy T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2017-2028
6.5.7 Russia T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2017-2028
6.5.8 Nordic Countries T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2017-2028
6.5.9 Benelux T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2017-2028
6.6.2 By Region - Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, 2017-2028
6.6.3 China T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2017-2028
6.6.4 Japan T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2017-2028
6.6.5 South Korea T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2017-2028
6.6.6 Southeast Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2017-2028
6.6.7 India T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2017-2028
6.7.2 By Country - South America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, 2017-2028
6.7.3 Brazil T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2017-2028
6.7.4 Argentina T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, 2017-2028
6.8.3 Turkey T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2017-2028
6.8.4 Israel T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2017-2028
6.8.5 Saudi Arabia T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2017-2028
6.8.6 UAE T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Amgen
7.1.1 Amgen Corporate Summary
7.1.2 Amgen Business Overview
7.1.3 Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.1.4 Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2017-2022)
7.1.5 Amgen Key News
7.2 Immunocore
7.2.1 Immunocore Corporate Summary
7.2.2 Immunocore Business Overview
7.2.3 Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.2.4 Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2017-2022)
7.2.5 Immunocore Key News
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Corporate Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.3.4 Johnson & Johnson T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2017-2022)
7.3.5 Johnson & Johnson Key News
7.4 Roche
7.4.1 Roche Corporate Summary
7.4.2 Roche Business Overview
7.4.3 Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.4.4 Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2017-2022)
7.4.5 Roche Key News
7.5 Pfizer
7.5.1 Pfizer Corporate Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.5.4 Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2017-2022)
7.5.5 Pfizer Key News
7.6 AbbVie
7.6.1 AbbVie Corporate Summary
7.6.2 AbbVie Business Overview
7.6.3 AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.6.4 AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2017-2022)
7.6.5 AbbVie Key News
7.7 MacroGenics
7.7.1 MacroGenics Corporate Summary
7.7.2 MacroGenics Business Overview
7.7.3 MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.7.4 MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2017-2022)
7.7.5 MacroGenics Key News
7.8 Regeneron
7.8.1 Regeneron Corporate Summary
7.8.2 Regeneron Business Overview
7.8.3 Regeneron T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.8.4 Regeneron T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2017-2022)
7.8.5 Regeneron Key News
8 GLOBAL T-CELL & NK-CELL ENGAGING BISPECIFIC ANTIBODIES PRODUCTION CAPACITY, ANALYSIS
8.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Production Capacity, 2017-2028
8.2 T-Cell & NK-Cell Engaging Bispecific Antibodies Production Capacity of Key Manufacturers in Global Market
8.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 T-CELL & NK-CELL ENGAGING BISPECIFIC ANTIBODIES SUPPLY CHAIN ANALYSIS
10.1 T-Cell & NK-Cell Engaging Bispecific Antibodies Industry Value Chain
10.2 T-Cell & NK-Cell Engaging Bispecific Antibodies Upstream Market
10.3 T-Cell & NK-Cell Engaging Bispecific Antibodies Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 T-Cell & NK-Cell Engaging Bispecific Antibodies Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL T-CELL & NK-CELL ENGAGING BISPECIFIC ANTIBODIES OVERALL MARKET SIZE
2.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size: 2021 VS 2028
2.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, Prospects & Forecasts: 2017-2028
2.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top T-Cell & NK-Cell Engaging Bispecific Antibodies Players in Global Market
3.2 Top Global T-Cell & NK-Cell Engaging Bispecific Antibodies Companies Ranked by Revenue
3.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Companies
3.4 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Companies
3.5 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 T-Cell & NK-Cell Engaging Bispecific Antibodies Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers T-Cell & NK-Cell Engaging Bispecific Antibodies Product Type
3.8 Tier 1, Tier 2 and Tier 3 T-Cell & NK-Cell Engaging Bispecific Antibodies Players in Global Market
3.8.1 List of Global Tier 1 T-Cell & NK-Cell Engaging Bispecific Antibodies Companies
3.8.2 List of Global Tier 2 and Tier 3 T-Cell & NK-Cell Engaging Bispecific Antibodies Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size Markets, 2021 & 2028
4.1.2 T-Cell Engagers
4.1.3 NK-Cell Engagers
4.2 By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue & Forecasts
4.2.1 By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2017-2022
4.2.2 By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2023-2028
4.2.3 By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2017-2028
4.3 By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales & Forecasts
4.3.1 By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, 2017-2022
4.3.2 By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, 2023-2028
4.3.3 By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2017-2028
4.4 By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2021 & 2028
5.1.2 Hematological Cancers
5.1.3 Solid Tumors
5.2 By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue & Forecasts
5.2.1 By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2017-2022
5.2.2 By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2023-2028
5.2.3 By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2017-2028
5.3 By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales & Forecasts
5.3.1 By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, 2017-2022
5.3.2 By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, 2023-2028
5.3.3 By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2017-2028
5.4 By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2021 & 2028
6.2 By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue & Forecasts
6.2.1 By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2017-2022
6.2.2 By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2023-2028
6.2.3 By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2017-2028
6.3 By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales & Forecasts
6.3.1 By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, 2017-2022
6.3.2 By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, 2023-2028
6.3.3 By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2017-2028
6.4.2 By Country - North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, 2017-2028
6.4.3 US T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2017-2028
6.4.4 Canada T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2017-2028
6.4.5 Mexico T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2017-2028
6.5.2 By Country - Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, 2017-2028
6.5.3 Germany T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2017-2028
6.5.4 France T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2017-2028
6.5.5 U.K. T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2017-2028
6.5.6 Italy T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2017-2028
6.5.7 Russia T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2017-2028
6.5.8 Nordic Countries T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2017-2028
6.5.9 Benelux T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2017-2028
6.6.2 By Region - Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, 2017-2028
6.6.3 China T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2017-2028
6.6.4 Japan T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2017-2028
6.6.5 South Korea T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2017-2028
6.6.6 Southeast Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2017-2028
6.6.7 India T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2017-2028
6.7.2 By Country - South America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, 2017-2028
6.7.3 Brazil T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2017-2028
6.7.4 Argentina T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, 2017-2028
6.8.3 Turkey T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2017-2028
6.8.4 Israel T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2017-2028
6.8.5 Saudi Arabia T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2017-2028
6.8.6 UAE T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Amgen
7.1.1 Amgen Corporate Summary
7.1.2 Amgen Business Overview
7.1.3 Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.1.4 Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2017-2022)
7.1.5 Amgen Key News
7.2 Immunocore
7.2.1 Immunocore Corporate Summary
7.2.2 Immunocore Business Overview
7.2.3 Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.2.4 Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2017-2022)
7.2.5 Immunocore Key News
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Corporate Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.3.4 Johnson & Johnson T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2017-2022)
7.3.5 Johnson & Johnson Key News
7.4 Roche
7.4.1 Roche Corporate Summary
7.4.2 Roche Business Overview
7.4.3 Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.4.4 Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2017-2022)
7.4.5 Roche Key News
7.5 Pfizer
7.5.1 Pfizer Corporate Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.5.4 Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2017-2022)
7.5.5 Pfizer Key News
7.6 AbbVie
7.6.1 AbbVie Corporate Summary
7.6.2 AbbVie Business Overview
7.6.3 AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.6.4 AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2017-2022)
7.6.5 AbbVie Key News
7.7 MacroGenics
7.7.1 MacroGenics Corporate Summary
7.7.2 MacroGenics Business Overview
7.7.3 MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.7.4 MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2017-2022)
7.7.5 MacroGenics Key News
7.8 Regeneron
7.8.1 Regeneron Corporate Summary
7.8.2 Regeneron Business Overview
7.8.3 Regeneron T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.8.4 Regeneron T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2017-2022)
7.8.5 Regeneron Key News
8 GLOBAL T-CELL & NK-CELL ENGAGING BISPECIFIC ANTIBODIES PRODUCTION CAPACITY, ANALYSIS
8.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Production Capacity, 2017-2028
8.2 T-Cell & NK-Cell Engaging Bispecific Antibodies Production Capacity of Key Manufacturers in Global Market
8.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 T-CELL & NK-CELL ENGAGING BISPECIFIC ANTIBODIES SUPPLY CHAIN ANALYSIS
10.1 T-Cell & NK-Cell Engaging Bispecific Antibodies Industry Value Chain
10.2 T-Cell & NK-Cell Engaging Bispecific Antibodies Upstream Market
10.3 T-Cell & NK-Cell Engaging Bispecific Antibodies Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 T-Cell & NK-Cell Engaging Bispecific Antibodies Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of T-Cell & NK-Cell Engaging Bispecific Antibodies in Global Market
Table 2. Top T-Cell & NK-Cell Engaging Bispecific Antibodies Players in Global Market, Ranking by Revenue (2021)
Table 3. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Share by Companies, 2017-2022
Table 5. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Companies, (K Units), 2017-2022
Table 6. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers T-Cell & NK-Cell Engaging Bispecific Antibodies Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers T-Cell & NK-Cell Engaging Bispecific Antibodies Product Type
Table 9. List of Global Tier 1 T-Cell & NK-Cell Engaging Bispecific Antibodies Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 T-Cell & NK-Cell Engaging Bispecific Antibodies Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), 2017-2022
Table 15. By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), 2023-2028
Table 16. By Application – Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), 2017-2022
Table 20. By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), 2023-2028
Table 21. By Region – Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), 2017-2022
Table 25. By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), 2023-2028
Table 26. By Country - North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (K Units), 2017-2022
Table 29. By Country - North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (K Units), 2023-2028
Table 30. By Country - Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (K Units), 2017-2022
Table 33. By Country - Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (K Units), 2023-2028
Table 34. By Region - Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (K Units), 2017-2022
Table 37. By Region - Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (K Units), 2023-2028
Table 38. By Country - South America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (K Units), 2017-2022
Table 41. By Country - South America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (K Units), 2023-2028
Table 46. Amgen Corporate Summary
Table 47. Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 48. Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Immunocore Corporate Summary
Table 50. Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 51. Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Johnson & Johnson Corporate Summary
Table 53. Johnson & Johnson T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 54. Johnson & Johnson T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Roche Corporate Summary
Table 56. Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 57. Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Pfizer Corporate Summary
Table 59. Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 60. Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. AbbVie Corporate Summary
Table 62. AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 63. AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. MacroGenics Corporate Summary
Table 65. MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 66. MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Regeneron Corporate Summary
Table 68. Regeneron T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 69. Regeneron T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. T-Cell & NK-Cell Engaging Bispecific Antibodies Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 71. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Capacity Market Share of Key Manufacturers, 2020-2022
Table 72. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Production by Region, 2017-2022 (K Units)
Table 73. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Production by Region, 2023-2028 (K Units)
Table 74. T-Cell & NK-Cell Engaging Bispecific Antibodies Market Opportunities & Trends in Global Market
Table 75. T-Cell & NK-Cell Engaging Bispecific Antibodies Market Drivers in Global Market
Table 76. T-Cell & NK-Cell Engaging Bispecific Antibodies Market Restraints in Global Market
Table 77. T-Cell & NK-Cell Engaging Bispecific Antibodies Raw Materials
Table 78. T-Cell & NK-Cell Engaging Bispecific Antibodies Raw Materials Suppliers in Global Market
Table 79. Typical T-Cell & NK-Cell Engaging Bispecific Antibodies Downstream
Table 80. T-Cell & NK-Cell Engaging Bispecific Antibodies Downstream Clients in Global Market
Table 81. T-Cell & NK-Cell Engaging Bispecific Antibodies Distributors and Sales Agents in Global Market
Table 1. Key Players of T-Cell & NK-Cell Engaging Bispecific Antibodies in Global Market
Table 2. Top T-Cell & NK-Cell Engaging Bispecific Antibodies Players in Global Market, Ranking by Revenue (2021)
Table 3. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Share by Companies, 2017-2022
Table 5. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Companies, (K Units), 2017-2022
Table 6. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers T-Cell & NK-Cell Engaging Bispecific Antibodies Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers T-Cell & NK-Cell Engaging Bispecific Antibodies Product Type
Table 9. List of Global Tier 1 T-Cell & NK-Cell Engaging Bispecific Antibodies Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 T-Cell & NK-Cell Engaging Bispecific Antibodies Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), 2017-2022
Table 15. By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), 2023-2028
Table 16. By Application – Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), 2017-2022
Table 20. By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), 2023-2028
Table 21. By Region – Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), 2017-2022
Table 25. By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), 2023-2028
Table 26. By Country - North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (K Units), 2017-2022
Table 29. By Country - North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (K Units), 2023-2028
Table 30. By Country - Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (K Units), 2017-2022
Table 33. By Country - Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (K Units), 2023-2028
Table 34. By Region - Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (K Units), 2017-2022
Table 37. By Region - Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (K Units), 2023-2028
Table 38. By Country - South America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (K Units), 2017-2022
Table 41. By Country - South America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, (K Units), 2023-2028
Table 46. Amgen Corporate Summary
Table 47. Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 48. Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Immunocore Corporate Summary
Table 50. Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 51. Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Johnson & Johnson Corporate Summary
Table 53. Johnson & Johnson T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 54. Johnson & Johnson T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Roche Corporate Summary
Table 56. Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 57. Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Pfizer Corporate Summary
Table 59. Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 60. Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. AbbVie Corporate Summary
Table 62. AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 63. AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. MacroGenics Corporate Summary
Table 65. MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 66. MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Regeneron Corporate Summary
Table 68. Regeneron T-Cell & NK-Cell Engaging Bispecific Antibodies Product Offerings
Table 69. Regeneron T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. T-Cell & NK-Cell Engaging Bispecific Antibodies Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 71. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Capacity Market Share of Key Manufacturers, 2020-2022
Table 72. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Production by Region, 2017-2022 (K Units)
Table 73. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Production by Region, 2023-2028 (K Units)
Table 74. T-Cell & NK-Cell Engaging Bispecific Antibodies Market Opportunities & Trends in Global Market
Table 75. T-Cell & NK-Cell Engaging Bispecific Antibodies Market Drivers in Global Market
Table 76. T-Cell & NK-Cell Engaging Bispecific Antibodies Market Restraints in Global Market
Table 77. T-Cell & NK-Cell Engaging Bispecific Antibodies Raw Materials
Table 78. T-Cell & NK-Cell Engaging Bispecific Antibodies Raw Materials Suppliers in Global Market
Table 79. Typical T-Cell & NK-Cell Engaging Bispecific Antibodies Downstream
Table 80. T-Cell & NK-Cell Engaging Bispecific Antibodies Downstream Clients in Global Market
Table 81. T-Cell & NK-Cell Engaging Bispecific Antibodies Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. T-Cell & NK-Cell Engaging Bispecific Antibodies Segment by Type
Figure 2. T-Cell & NK-Cell Engaging Bispecific Antibodies Segment by Application
Figure 3. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2017-2028 (US$, Mn)
Figure 7. T-Cell & NK-Cell Engaging Bispecific Antibodies Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue in 2021
Figure 9. By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2017-2028
Figure 10. By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2017-2028
Figure 11. By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price (US$/Unit), 2017-2028
Figure 12. By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2017-2028
Figure 13. By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2017-2028
Figure 14. By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price (US$/Unit), 2017-2028
Figure 15. By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2017-2028
Figure 16. By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2017-2028
Figure 17. By Country - North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2017-2028
Figure 18. By Country - North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2017-2028
Figure 19. US T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 20. Canada T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2017-2028
Figure 23. By Country - Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2017-2028
Figure 24. Germany T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 25. France T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 27. Italy T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 28. Russia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2017-2028
Figure 32. By Region - Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2017-2028
Figure 33. China T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 34. Japan T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 37. India T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2017-2028
Figure 39. By Country - South America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2017-2028
Figure 40. Brazil T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2017-2028
Figure 44. Turkey T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 45. Israel T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 47. UAE T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 48. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production T-Cell & NK-Cell Engaging Bispecific Antibodies by Region, 2021 VS 2028
Figure 50. T-Cell & NK-Cell Engaging Bispecific Antibodies Industry Value Chain
Figure 51. Marketing Channels
Figure 1. T-Cell & NK-Cell Engaging Bispecific Antibodies Segment by Type
Figure 2. T-Cell & NK-Cell Engaging Bispecific Antibodies Segment by Application
Figure 3. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2017-2028 (US$, Mn)
Figure 7. T-Cell & NK-Cell Engaging Bispecific Antibodies Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue in 2021
Figure 9. By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2017-2028
Figure 10. By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2017-2028
Figure 11. By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price (US$/Unit), 2017-2028
Figure 12. By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2017-2028
Figure 13. By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2017-2028
Figure 14. By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price (US$/Unit), 2017-2028
Figure 15. By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2017-2028
Figure 16. By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2017-2028
Figure 17. By Country - North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2017-2028
Figure 18. By Country - North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2017-2028
Figure 19. US T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 20. Canada T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2017-2028
Figure 23. By Country - Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2017-2028
Figure 24. Germany T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 25. France T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 27. Italy T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 28. Russia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2017-2028
Figure 32. By Region - Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2017-2028
Figure 33. China T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 34. Japan T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 37. India T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2017-2028
Figure 39. By Country - South America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2017-2028
Figure 40. Brazil T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2017-2028
Figure 44. Turkey T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 45. Israel T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 47. UAE T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$, Mn), 2017-2028
Figure 48. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production T-Cell & NK-Cell Engaging Bispecific Antibodies by Region, 2021 VS 2028
Figure 50. T-Cell & NK-Cell Engaging Bispecific Antibodies Industry Value Chain
Figure 51. Marketing Channels
